Bespoke Extracts (BSPK) Payables (2011 - 2025)
Bespoke Extracts (BSPK) reported Payables of $1.4 million for Q3 2025, down 3.68% on a YoY basis from $1.5 million in Q3 2024, and up 4.31% sequentially from $1.4 million in Q2 2025.
Bespoke Extracts (BSPK) Payables (2011 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 15 years of Payables data on file, last reported at $1.4 million in Q3 2025.
- For the quarter ending Q3 2025, Payables fell 3.68% year-over-year to $1.4 million; the trailing twelve-month figure through Sep 2025 stood at $1.4 million (down 3.68% YoY), and the FY2024 full-year result was $978276.0, up 1.77% from the prior year.
- Payables rose to $1.4 million in Q3 2025, from $1.4 million in the prior quarter.
- In the past five years, Payables ranged from a high of $1.5 million in Q3 2024 to a low of $42762.0 in Q3 2021.
- A 5-year average of $749609.3 and a median of $855066.0 in 2023 frame the typical range for Payables.
- Across the five-year window, Payables sank 76.23% in 2021 and surged 555.83% in 2023, its largest moves.
- Tracing BSPK's Payables over 5 years: stood at $121830.0 in 2021, then jumped by 216.69% to $385818.0 in 2022, then surged by 149.15% to $961255.0 in 2023, then grew by 1.77% to $978276.0 in 2024, then surged by 44.94% to $1.4 million in 2025.
- Business Quant data shows BSPK's Payables at $1.4 million in Q3 2025, $1.4 million in Q2 2025, and $1.1 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 731.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 8.82 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.42 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 978,276.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.45 Mn |
| Mar 31, 2024 | 1.22 Mn |
| Dec 31, 2023 | 961,255.00 |
| Sep 30, 2023 | 855,066.00 |
| Jun 30, 2023 | 683,838.00 |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 385,818.00 |
| Sep 30, 2022 | 379,841.00 |
| Jun 30, 2022 | 234,022.00 |
| Mar 31, 2022 | 180,621.00 |
| Nov 30, 2021 | 121,830.00 |
| Aug 31, 2021 | 42,762.00 |
| May 31, 2021 | 62,670.00 |
| Feb 28, 2021 | 116,462.00 |
| Nov 30, 2020 | 201,018.00 |